Log In
Print
BCIQ
Print
Print this Print this
 

NanoBUP (buprenorphine / naloxone)

  Manage Alerts
Collapse Summary General Information
Company Nanotherapeutics Inc.
DescriptionCapsule containing a fixed-dose combination (4:1) of buprenorphine and naloxone
Molecular Target Mu opioid receptor (OPRM1) (MOR) ; Kappa opioid receptor (OPRK1) (KOR)
Mechanism of ActionMu opioid receptor agonist/antagonist; Opioid receptor antagonist; Kappa opioid receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationAddiction
Indication DetailsTreat opiate dependence
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today